CD&R confirms higher £2.7bn offer for UDG Healthcare
US private equity firm Clayton, Dubilier & Rice on Tuesday confirmed its increased final £2.7bn offer for Dublin-based UDG Healthcare.
FTSE 250
20,591.40
17:00 03/01/25
FTSE 350
4,534.15
16:54 03/01/25
FTSE All-Share
4,490.88
17:14 03/01/25
Health Care Equipment & Services
10,644.60
16:54 03/01/25
UDG Healthcare Public Limited Company (CDI)
1,079.00p
16:34 13/08/21
CD&R, which is also seeking to take over the UK supermarket chain Morrisons, lifted its bid to £10.80 a share, UDG said in a statement to the stock market, adding that the board had agreed to its terms.
The initial offer of £10.23, made in May, was opposed by major shareholders, Allianz Global Investors and M&G who said it undervalued the company
Rory Alexander, a fund manager at M&G, last week said while the group was “pleased” that CD&R had upped its bid, “a potential offer of £10.80 would still fall short of our expectations on behalf of our customers”, the Financial Times reported last Friday.
UDG on Tuesday said M&G and Kabouter Management, who hold 11.41% of the company between them, supported the improved bid.
A vote on the deal will take place next month at the company’s head office in Dublin unless an outside bid is received, in which case CD&R may increase its offer.
UDG operates two divisions and employs around 9,000 workers across 29 countries. Its largest division, Ashfield, is a global healthcare services business working in advisory, marketing and communications, while the other unit Sharp, is a contract packaging, clinical, manufacturing and technology services business.